News
AstraZeneca and Novavax say their vaccines are effective against Omicron
WHO officials remain cautious about claiming Omicron as a milder variant of the COVID-19 virus.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
WHO officials remain cautious about claiming Omicron as a milder variant of the COVID-19 virus.